Hedgehog signalling in prostate regeneration, neoplasia and metastasis
- PMID: 15361885
- DOI: 10.1038/nature02962
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
Abstract
Metastatic cancers adopt certain properties of normal cells in developing or regenerating organs, such as the ability to proliferate and alter tissue organization. We find here that activity of the Hedgehog (Hh) signalling pathway, which has essential roles in developmental patterning, is required for regeneration of prostate epithelium, and that continuous pathway activation transforms prostate progenitor cells and renders them tumorigenic. Elevated pathway activity furthermore distinguishes metastatic from localized prostate cancer, and pathway manipulation can modulate invasiveness and metastasis. Pathway activity is triggered in response to endogenous expression of Hh ligands, and is dependent upon the expression of Smoothened, an essential Hh response component that is not expressed in benign prostate epithelial cells. Monitoring and manipulating Hh pathway activity may thus offer significant improvements in diagnosis and treatment of prostate cancers with metastatic potential.
Comment in
-
Hedgehog signalling in prostate regeneration, neoplasia and metastasis.J Urol. 2005 Apr;173(4):1169. doi: 10.1097/01.ju.0000156734.69186.57. J Urol. 2005. PMID: 15758729 No abstract available.
Similar articles
-
Hedgehog stimulates only osteoblastic differentiation of undifferentiated KS483 cells.Bone. 2003 Dec;33(6):899-910. doi: 10.1016/j.bone.2003.07.004. Bone. 2003. PMID: 14678849
-
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer.Nature. 2003 Mar 20;422(6929):313-7. doi: 10.1038/nature01493. Epub 2003 Mar 5. Nature. 2003. PMID: 12629553
-
Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer.Cancer Res. 2005 Apr 15;65(8):2990-2. doi: 10.1158/0008-5472.CAN-05-0439. Cancer Res. 2005. PMID: 15833820 Review.
-
Hedgehog pathway activity in the LADY prostate tumor model.Mol Cancer. 2007 Mar 7;6:19. doi: 10.1186/1476-4598-6-19. Mol Cancer. 2007. PMID: 17343742 Free PMC article.
-
Interference with HH-GLI signaling inhibits prostate cancer.Trends Mol Med. 2005 May;11(5):199-203. doi: 10.1016/j.molmed.2005.03.004. Trends Mol Med. 2005. PMID: 15882606 Review.
Cited by
-
The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects.Biomedicines. 2024 Sep 2;12(9):1979. doi: 10.3390/biomedicines12091979. Biomedicines. 2024. PMID: 39335494 Free PMC article. Review.
-
PRMT5-mediated methylation of STAT3 is required for lung cancer stem cell maintenance and tumour growth.Commun Biol. 2024 May 17;7(1):593. doi: 10.1038/s42003-024-06290-7. Commun Biol. 2024. PMID: 38760429 Free PMC article.
-
Pharmacology of Veratrum californicum Alkaloids as Hedgehog Pathway Antagonists.Pharmaceuticals (Basel). 2024 Jan 17;17(1):123. doi: 10.3390/ph17010123. Pharmaceuticals (Basel). 2024. PMID: 38256956 Free PMC article.
-
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies.Cell Commun Signal. 2024 Jan 12;22(1):36. doi: 10.1186/s12964-023-01462-0. Cell Commun Signal. 2024. PMID: 38216942 Free PMC article. Review.
-
GREB1L overexpression is associated with good clinical outcomes in breast cancer.Eur J Med Res. 2023 Nov 14;28(1):510. doi: 10.1186/s40001-023-01483-y. Eur J Med Res. 2023. PMID: 37964281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
